There is a lot of execution risk with mem, their record of delivery is poor. Delays are almost certain. The study may also not be as conclusive as we hope however the Japanese paper reduces this risk considerably (do a google search for it). If it is good, like Kenji says, it is hard to see it not being the preferred option. Then there is however regulatory risk like was saw in India.
Im confident in success here with Felix and more so with animals down the track. The TAM is big and growing fast. Just government funding in Japan like our peers will see our market cap skyrocket. Risk reward is there for me.
Ann: Heranova Felix System Utilisation Testing commences in China, page-46
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $7.934M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $4.914K | 1.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 10032150 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 2431903 | 2 |
View Market Depth
| Last trade - 13.25pm 16/06/2025 (20 minute delay) ? |
| MEM (ASX) Chart |